[Reevaluation of current antimicrobials. Ceftazidime].
Urabe
A
A
Inamatsu
T
T
D000368:Aged; D016470:Bacteremia / Q000188:drug therapy; D001424:Bacterial Infections / Q000188:drug therapy / Q000517:prevention & control; D002442:Ceftazidime / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects
D016179:Granulocyte Colony-Stimulating Factor; D002442:Ceftazidime